Related Experiment Video
Updated: Dec 27, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Evaluation of Pathway Activation for a Single Sample Toward Inflammatory Bowel Disease Classification
Xingyi Li1, Min Li1, Ruiqing Zheng1
1School of Computer Science and Engineering, Central South University, Changsha, China.
Accurately diagnosing similar complex diseases is challenging. Pathway Activation for Single Sample (PASS) offers a novel framework to identify pathway biomarkers for precise disease classification and understanding biological mechanisms.
Area of Science:
- Computational biology
- Systems biology
- Bioinformatics
Background:
- Similar complex diseases often present with overlapping clinical symptoms, leading to misdiagnosis and mistreatment.
- Existing network-based prediction methods lack robustness and reproducibility.
- Pathway-based methods offer interpretability but often fail to characterize single-sample disease states.
Purpose of the Study:
- To develop a novel framework, Pathway Activation for Single Sample (PASS), for accurate classification of similar complex diseases.
- To enable precise diagnosis and identification of pathway biomarkers for individual patients.
- To explore disease-specific pathway alterations in single samples.
Main Methods:
- PASS quantifies pathway perturbation by assessing edge alterations and gene statistics within single samples.
- A novel method, AUCpath, evaluates pathway activation based on gene interactions and statistics.
- The framework was applied to differentiate between subtypes of inflammatory bowel disease (IBD).
Main Results:
- PASS demonstrated effectiveness in recognizing differences between similar complex diseases.
- The framework successfully applied to inflammatory bowel disease subtypes.
- PASS features show potential as interpretable indicators for precise diagnosis.
Conclusions:
- PASS provides a robust and interpretable method for single-sample disease state characterization.
- The framework facilitates the discovery of pathway biomarkers for complex diseases.
- PASS aids in understanding the biological mechanisms underlying disease variations.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

